Nanomaterials for Biomedical and Biotechnological Applications
The need for constant improvement to reach a high standard of safety and to make nanomaterials accessible for marketing has generated a considerable number of scientific papers that highlight new important aspects to be considered, such as synthesis, stability, biocompatibility, and easy manipulatio...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (266 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04131nam-a2201213z--4500 | ||
|---|---|---|---|
| 001 | 993553547704498 | ||
| 005 | 20231214132941.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202208s2022 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5600000000483103 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/91169 | ||
| 035 | |a (EXLCZ)995600000000483103 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Ferraro, Angelo |4 edt | |
| 245 | 1 | 0 | |a Nanomaterials for Biomedical and Biotechnological Applications |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (266 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a The need for constant improvement to reach a high standard of safety and to make nanomaterials accessible for marketing has generated a considerable number of scientific papers that highlight new important aspects to be considered, such as synthesis, stability, biocompatibility, and easy manipulation. In order to provide a comprehensive update on the latest discoveries concerning nanomaterials, this reprint presents 14 scientific papers, 10 research articles and 4 reviews, that deal with biomedical and biotechnological applications of nanomaterials. | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 650 | 7 | |a Biotechnology |2 bicssc | |
| 653 | |a neurodegenerative disease | ||
| 653 | |a cerium oxide nanoparticles | ||
| 653 | |a Parkinson's disease | ||
| 653 | |a oxidative stress | ||
| 653 | |a physicochemical properties | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a synthesis methods | ||
| 653 | |a magnetic driving | ||
| 653 | |a magnetic nanoparticles | ||
| 653 | |a actuation system | ||
| 653 | |a drug targeting | ||
| 653 | |a chitosan | ||
| 653 | |a clay | ||
| 653 | |a nanocomposite films | ||
| 653 | |a papain | ||
| 653 | |a covalent immobilization | ||
| 653 | |a wine | ||
| 653 | |a magnetic gels | ||
| 653 | |a drug release | ||
| 653 | |a magnetic hyperthermia | ||
| 653 | |a magnetic lipogels | ||
| 653 | |a supramolecular hydrogels | ||
| 653 | |a self-assembly | ||
| 653 | |a nanoparticle functionalization | ||
| 653 | |a organic and inorganic nanoparticles | ||
| 653 | |a ophthalmic applications | ||
| 653 | |a clinical trials | ||
| 653 | |a orthopedic | ||
| 653 | |a nanomedicine | ||
| 653 | |a nanomodified surfaces | ||
| 653 | |a animal model | ||
| 653 | |a immune response | ||
| 653 | |a Chlorella vulgaris | ||
| 653 | |a microwave-synthesized magnetite particles | ||
| 653 | |a response surface methodology | ||
| 653 | |a harvesting process optimization | ||
| 653 | |a optimization | ||
| 653 | |a economic analysis | ||
| 653 | |a plant design and process engineering | ||
| 653 | |a cubic particles | ||
| 653 | |a COVID-19 | ||
| 653 | |a nanotechnology | ||
| 653 | |a vaccines | ||
| 653 | |a sanitizers | ||
| 653 | |a biosensors | ||
| 653 | |a restricted access media | ||
| 653 | |a nanofibers | ||
| 653 | |a microfibers | ||
| 653 | |a on-line extraction | ||
| 653 | |a biological samples | ||
| 653 | |a column-switching chromatography | ||
| 653 | |a theranostic nanomaterials | ||
| 653 | |a boron nitride | ||
| 653 | |a neutron capture reaction | ||
| 653 | |a nuclear medicine | ||
| 653 | |a drug delivery | ||
| 653 | |a antibiotics | ||
| 653 | |a antimicrobial resistance | ||
| 653 | |a gold nanoparticles | ||
| 653 | |a ciprofloxacin | ||
| 653 | |a Enterococcus faecalis | ||
| 653 | |a liver and kidney infections | ||
| 653 | |a colorectal cancer | ||
| 653 | |a biomarkers | ||
| 653 | |a cytotoxic medication | ||
| 653 | |a genetic pathways | ||
| 653 | |a epigenetic changes | ||
| 653 | |a prognostic | ||
| 653 | |a phytomedicine | ||
| 653 | |a rheumatoid arthritis | ||
| 653 | |a methotrexate | ||
| 653 | |a anti-arthritic activity | ||
| 653 | |a nanoemulsion | ||
| 653 | |a hemocompatibility | ||
| 653 | |a MTT assay | ||
| 653 | |a stability studies | ||
| 776 | |z 3-0365-4700-2 | ||
| 776 | |z 3-0365-4699-5 | ||
| 700 | 1 | |a Ferraro, Angelo |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:37:41 Europe/Vienna |f system |c marc21 |a 2022-08-13 21:17:26 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339474120004498&Force_direct=true |Z 5339474120004498 |b Available |8 5339474120004498 | ||